About
NuvOx Therapeutics is a clinical-stage pharmaceutical company developing oxygen therapeutics to enhance oxygen delivery for diseases such as stroke, glioblastoma, oncology, and respiratory distress, with ongoing clinical trials supported by government grants.
Explore NuvOx Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.